Here’s a conversation that I hope will motivate you to look into the references a bit. Gene drives have the potential to eliminate scourges like malaria – if we can develop the technology without provoking social license problems.
Category: Biotech
pando_ruffus 0.1.37
Pando_ruffus is a bioinformatics tool for for exploring and characterising bacterial genome data. Input is paired-end reads and assemblies.
Area students earn Dean’s List honors
A number of local students were recently named to the Clemson University Dean’s List for the fall 2016 semester. From Elgin: Eric Charles Bell, architecture; Margaret Wells Chase, communication; Alexa M. Cox, biochemistry; Meisha C. Draper, electrical engineering; Katherine Moira Hoskins, sociology; Keenan K. Hunt, communication; Margaret Mary Laporte, health science; Mallory Grace Mullen, secondary education; Devin Thomas Reeder, architecture; Kelsey Renee Stuhn, environmental engineering; Linda S. Thomas, bioengineering; Zachary Stuart Vandenberg, English; Megan P. Vandiver, nursing; Rose Marie Werden, general engineering; and Blakeley E. Yandle, parks, recreation and tourism management.
Berkeley engineers join $24 million push for craniofacial repair therapies
Kevin Healy, professor of bioengineering and materials science and engineering, leads Berkeley’s role in a new craniofacial research center, C-DOCTOR. UC Berkeley is part of a California-based, six-university consortium that has been awarded $12 million by the National Institutes of Health to develop strategies for treating craniofacial defects, which affect millions of Americans.
Biohaven closes second tranche of $80 mln private placement
Biohaven Pharmaceutical Holding Company Ltd , a clinical stage biopharmaceutical company targeting neurological diseases, including rare disorders, has closed the second tranche of its $80 million private placement. Venrock was the lead investor.
Epicrop rakes in $3.2 mln
Lincoln, Nebraska-based Epicrop Technologies Inc , an agricultural biotech company, has raised $3.2 million in Series A funding. The investors were TechAccel, North Forty Ventures, Nelnet, Speedway Properties and Allen & Company .
The 2-Second Investment System: Taking Luck Out Of The Win-Lose Equation
What does luck have to do with making money in the stock market? There are only two possible answers to that question: Everything or Nothing. I’ve been trading stocks for over 35 years.
Arkansas House of Representatives Weekly Column
This session, the House has passed a number of bills aimed at not only creating jobs, but sustaining them and ensuring our workforce is ready. Act 166 creates a state matching grant for small businesses that have received a federal Small Business Innovation Research grant.
Fairchild Wheeler Interdistrict Magnet School in Bridgeport, Conn. March 2, 2017.
Lauren Wokanovicz, right, of Shelton, and Neilissa Dagraca, left, of Stratford, both sophomore Biotech students at Fairchild Wheeler Interdistrict Magnet School attend their Human Phsiology class in Bridgeport, Conn. March 2, 2017.
Bridgeport schools are magnet for controversy
Lauren Wokanovicz, right, of Shelton, and Neilissa Dagraca, left, of Stratford, both sophomore Biotech students at Fairchild Wheeler Interdistrict Magnet School attend their Human Phsiology class in Bridgeport, Conn. March 2, 2017.
Invivoscribe Expands Ion PGM(TM) NGS Platform Menu: Releases…
Invivoscribe Technologies Inc., a global company with more than 20 years of experience providing clonality and biomarker test solutions for the fields of oncology, personalized molecular diagnostics and personalized molecular medicine , today released three additional CE-marked next-generation sequencing assay kits for in vitro diagnostic use to assist in the diagnosis of B-cell malignancies. Invivoscribe has now commercialized more than 40 CE-IVD assays and bioinformatics packages for capillary electrophoresis and NGS platforms and has recently announced a long-term agreement with Thermo Fisher Scientific to bring regulated IVD assays through the FDA on the Ion PGM Dx System.
Novavax Reports Fourth Quarter and Year-End 2016 Financial Results
Novavax, Inc., today announced its financial results for the fourth quarter and twelve months ended December 31, 2016. Continued execution of the global Phase 3 PrepareTM clinical trial to prevent RSV in infants via maternal immunization.
Life Technologies Corp. v. Promega Corp. and the Absent Presumption Against Extraterritoriality
Guest Post by Tim Holbrook, Professor of Law at Emory University School of Law. Professor Holbrook has written extensively on the extraterritorial application of U.S. patent law.
BRIEF-Changsheng Bio Technology plans bio-tech JV
* Seeks members’ nod for issue of equity shares via QIP for qualified institutional buyers Source text: Further company coverage:
3 Stocks That Are Ridiculously Cheap Right Now
With our stock market trading near all-time highs today, it might seem crazy to put new investing dollars to work right now. But for value-oriented investors who know where to look, there are always enticing deals to be found.
Revenue hike fuels hope
Guwahati, Feb. 25: Revenue from the Guwahati Biotech Park, the first biotechnology park in the Northeast, has steadily increased over the past two years. Chief executive officer of the park Vinod Seshan disclosed this on the sidelines of the park’s foundation day celebrations at Shilpgram here today.
Revenue hike fuels hope
Guwahati, Feb. 25: Revenue from the Guwahati Biotech Park, the first biotechnology park in the Northeast, has steadily increased over the past two years. Chief executive officer of the park Vinod Seshan disclosed this on the sidelines of the park’s foundation day celebrations at Shilpgram here today.
First Year Postdoctoral Research Fellow in Computational Biology / Bioinformatics
We are looking for a highly motivated first-year postdoctoral fellow interested in developing computational methods related to expression quantitative trait, alternative splicing, transcriptome-wide association studies and chromatin structures in normal and glioma cells. The post-doc will be jointly supervised by Drs.
Report by U.S. Government Research Scientists Confirms Bio Terror…
Pacific National Northwest Laboratory researchers find CANARY Technology had best detection sensitivity for Ricin and Anthrax of any comparable technology evaluated. Baltimore biotech firm, PathSensors, Inc., announced today that in a published evaluation of multiple immunoassay-based threat detection technologies by researchers from the Pacific National Northwest Laboratory , a U.S. Department of Energy Laboratory, PathSensors’ CANARY biosensor threat detection technology was found to have the best level of detection for two bio terror threats, Bacillus anthracis and Ricin.
Press release distribution, EDGAR filing, XBRL, regulatory filings
For the fourth quarter of 2016, Green Dot reported GA… )–Cloud Peak Energy Inc. announced that it has commenced a registered underwritten public offering of 13,500,000 shares of its common stock.
Pharma and Biotechnology Consulting Firm Announces European Director
Biotech and pharma consulting firm Pennside Partners, Ltd., announced the addition of Tom Perkins as European director, operating from Pennside’s Zurich, Switzerland headquarters. Pharma and biotech consulting firm Pennside Partners, Ltd ., announced the addition of Tom Perkins as European director.
Short Interest in Novavax, Inc. (NVAX) Decreases By 1.9%
Novavax, Inc. was the recipient of a significant drop in short interest in the month of January. As of January 31st, there was short interest totalling 63,797,973 shares, a drop of 1.9% from the January 13th total of 65,010,684 shares.
Gene editing patent ruling sways fortune of biotech hopefuls
In a highly anticipated decision that could sway the fortunes of a handful of biotechnology companies, the federal patent office has turned back a challenge to patents covering a widely used method for editing genes. The office’s board of appeals ruled Wednesday that the Broad Institute of MIT and Harvard can keep patents it had been awarded for a technique called CRISPR that lets scientists alter DNA within cells.
Why One Analyst Eyes Opportunity in Biotech
The biotech sector has enjoyed a solid week of gains indicative of the iShares Nasdaq Biotechnology Index ETF climbing over 3.5% in the past five trading sessions. “On a short-term basis, it is probably a little ahead of itself but, I like the names,” 55 Capital market strategist Max Wolff said on CNBC’s “Power Lunch” Friday afternoon.
Gene Editing Patent Ruling Sways Fortune of Biotech Hopefuls
In a highly anticipated decision that could sway the fortunes of a handful of biotechnology companies, the federal patent office has turned back a challenge to patents covering a widely used method for editing genes. The office’s board of appeals ruled Wednesday that the Broad Institute of MIT and Harvard can keep patents it had been awarded for a technique called CRISPR that lets scientists alter DNA within cells.
Suzuken Group Deploys RFID-Enabled Coolers for Drug Tracking
Japanese healthcare and pharmaceuticals company Suzuken Group is deploying an RFID-based solution from AmerisourceBergen to manage the locations and statuses of medications at clinics, hospitals and retail locations, as well as in transportation vehicles. The system employs the RFID-based drug-management solution known as Cubixx, supplied by AmerisourceBergen’s specialty pharmaceutical distributor division, ASD Healthcare.
How UC-Berkeley’s CRISPR license could limit innovation
A smart biotech company could have a great idea for how to use gene editing to develop a new lifesaving therapy – but because of the way licensing deals have been cut by UC-Berkeley and Massachusetts’ Broad Institute, it would never get a chance to try it. That’s the assertion of intellectual property experts in Friday’s issue of the journal Science, who criticize the licensing landscape around the powerful new tool called CRISPR-Cas9, warning it could limit its promise.
Illinois lawmakers propose biotech tax credits
The legislation, introduced by Republican state Sen. Chapin Rose of Mahomet and Democratic state Sen. Andy Manar of Bunker Hill, would provide incentives to produce and sell new renewable products made from biomass and other renewable sources, the Herald & Review reported. “We have leading biotechnology companies, large and small, that are leading research and development efforts on these innovative products, and we have critical mass in infrastructure to produce and transport these renewables around the world,” Manar said.
Newly discovered breast stem cells wake up when exposed to ovarian hormones
Walter and Eliza Hall Institute researchers have used advanced cellular, bioinformatics and imaging technology to reveal a long-lived type of stem cell in the breast that is responsible for the growth of the mammary glands during pregnancy. The newly discovered stem cells, which respond to the ‘ovarian hormones’ progesterone and oestrogen, may also be linked to a high-risk form of breast cancer.
Newly discovered breast stem cells wake up when exposed to ovarian hormones
Walter and Eliza Hall Institute researchers have used advanced cellular, bioinformatics and imaging technology to reveal a long-lived type of stem cell in the breast that is responsible for the growth of the mammary glands during pregnancy. The newly discovered stem cells, which respond to the ‘ovarian hormones’ progesterone and oestrogen, may also be linked to a high-risk form of breast cancer.
Now you can “build your own” bio-bot
For the past several years, researchers at the University of Illinois at Urbana-Champaign have been developing a class of walking “bio-bots” powered by muscle cells and controlled with electrical and optical pulses. Now, Rashid Bashir’s bioengineering research group is sharing the recipe for the current generation of bio-bots.
Neogen Corporation (NEOG) Stake Held by Bamco Inc. NY
Bamco Inc. NY continued to hold its position in shares of Neogen Corporation during the third quarter, Holdings Channel reports. The institutional investor owned 444,596 shares of the company’s stock at the end of the third quarter.
Biotech leaders blast Trump’s immigration order
More than 160 leaders of biotechnology companies signed a strong letter of opposition to President Trump’s travel ban, arguing the ”poorly conceived and implemented” action strikes at the heart of an industry that originated in America, has been dominated by American companies, and is at the cutting edge of medicine. The letter, published Tuesday by the journal Nature Biotechnology, reveals that scientists abroad are afraid to come to the United States and are canceling trips.
Mission Bio Receives Investment from Life Science Angels
Mission Bio, Inc. announced today that it has secured funding from U.S. top ranked angel investment group Life Science Angels in a seed round to commercialize its high throughput single-cell genomics system. Mission Bio is developing a microfluidic, droplet-based platform to enable critical advances in diseases like cancer, where elucidating heterogeneity in cell populations is essential.
10-year-old Texas boy invents device to prevent hot car deaths
Bishop Curry V, a 10-year-old Texas boy, has invented a device that could eventually save the lives of babies across the country by alerting parents and keeping the child cool if for some reason it were to be forgotten in a hot car. Photo: Curry Bishop GoFundMe Bishop Curry V, a 10-year-old Texas boy, has invented a device that could eventually save the lives of babies across the country by alerting parents and keeping the child cool if for some reason it were to be … more Aug. 24, 2013: A third mirror is installed into the Giant Megellan Telescope, which, when completed, will produce images 10 times sharper than the Hubble Telescope.
buddysuite 1.2.5
The BuddySuite modules are ‘one-stop-shop’ command-line tools for common biological data file manipulations. Formats are detected automatically, conversions are seamless, and you can pipe into or out of the modules to build custom bioinformatics workflows, allowing you to spend more time analyzing your sequences, alignments, and phylogenetic trees, instead of wrangling them.
Cleanroom Doors Market Is Expected to Gain Popularity Across the Globe
Cleanrooms are controlled environment rooms with low levels of pollutants such as microorganisms, dust, chemical vapors and others. Cleanrooms are used in a wide range of industrial processes, where pollutants may obstruct and depreciate the quality of production.
A Framework for Incorporating Functional Interrelationships into…
IEEE/ACM Transactions on Computational Biology and Bioinformatics , Vol. 9, No. 3. , pp.
Research consortium awarded $21 million NIH grant to find ways to…
An international consortium of academic research institutions have been awarded a $21 million grant from the National Institutes of Health to develop better ways to prevent epilepsy in patients who have suffered traumatic brain injuries. The grant will be led by seven principal investigators at five institutions: Albert Einstein College of Medicine, David Geffen School of Medicine at UCLA, Keck School of Medicine at the University of Southern California, University of Melbourne and University of Eastern Finland.
Certara Corporation Releases New Version Of D360, Its…
CertaraA , the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced that it has released D360a version 9.0 along with D360 Express, its data informatics platform for discovery scientists. D360 is a self-service data access, integration and visualization solution used to query multiple cheminformatics and bioinformatics data sources and make informed go/no-go and next step research decisions.